LMU – Ludwig-Maximilians-University

Bio­med­ical Cen­ter Munich (PD Dr. Bastian Popper)


New Drug Can­did­ate Devel­op­ments - The CAM Core Facil­ity part­ners ISAR Bioscience

The Core Facil­ity (CAM) is glad to announce a new col­lab­or­a­tion with the drug dis­cov­ery and research com­pany ISAR Bioscience aimed at test­ing innov­at­ive thera­peutic prin­ciples and drug can­did­ates for the treat­ment of autoim­mune and neuro­de­gen­er­at­ive diseases.

ISAR Bioscience is devel­op­ing thera­peut­ics based on an mRNA plat­form tech­no­logy, as well as spe­cific anti­bod­ies tar­get­ing novel and dis­ease-rel­ev­ant mech­an­isms for the treat­ment of a broad range of diseases.
The com­pany is now car­ry­ing out pre­clin­ical stud­ies jointly with the CAM core facil­ity, which is espe­cially exper­i­enced in invest­ig­at­ing new thera­peut­ics in vivo.
The Core Facil­ity (CAM) at the Bio­med­ical Cen­ter is a sci­entific unit of the LMU Munich provid­ing sci­ent­ists a plat­form to develop thera­peut­ics in accord­ance with the legal require­ments of the European and national (Ger­man) law and reg­u­lat­ory author­it­ies. In addi­tion, the CAM team sup­ports sci­ent­ists dur­ing both the plan­ning and the real­iz­a­tion of the exper­i­ments, and provides tech­nical advice and expert coun­sel­ing in rela­tion to legal author­it­ies and gov­ern­ment offices.